- Home
- NSTS vs LSB Comparison
NSTS vs LSB Comparison
Compare NSTS & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- LSB
- Stock Information
- Founded
- NSTS 1921
- LSB 2002
- Country
- NSTS United States
- LSB China
- Employees
- NSTS N/A
- LSB N/A
- Industry
- NSTS Savings Institutions
- LSB
- Sector
- NSTS Finance
- LSB
- Exchange
- NSTS Nasdaq
- LSB NYSE
- Market Cap
- NSTS 59.9M
- LSB 49.8M
- IPO Year
- NSTS N/A
- LSB N/A
- Fundamental
- Price
- NSTS $11.35
- LSB $2.51
- Analyst Decision
- NSTS
- LSB
- Analyst Count
- NSTS 0
- LSB 0
- Target Price
- NSTS N/A
- LSB N/A
- AVG Volume (30 Days)
- NSTS 5.8K
- LSB 15.7K
- Earning Date
- NSTS 11-13-2024
- LSB 01-21-2025
- Dividend Yield
- NSTS N/A
- LSB N/A
- EPS Growth
- NSTS N/A
- LSB N/A
- EPS
- NSTS N/A
- LSB N/A
- Revenue
- NSTS $6,117,000.00
- LSB $79,415,311.00
- Revenue This Year
- NSTS N/A
- LSB $39.33
- Revenue Next Year
- NSTS N/A
- LSB $75.61
- P/E Ratio
- NSTS N/A
- LSB N/A
- Revenue Growth
- NSTS N/A
- LSB N/A
- 52 Week Low
- NSTS $9.20
- LSB $1.88
- 52 Week High
- NSTS $11.50
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- NSTS 56.82
- LSB 44.96
- Support Level
- NSTS $11.21
- LSB $2.10
- Resistance Level
- NSTS $11.40
- LSB $2.77
- Average True Range (ATR)
- NSTS 0.09
- LSB 0.36
- MACD
- NSTS -0.00
- LSB 0.01
- Stochastic Oscillator
- NSTS 78.95
- LSB 34.68
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.